Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery
Prostatic Neoplasms, Urinary Bladder Neoplasms
About this trial
This is an interventional treatment trial for Prostatic Neoplasms focused on measuring standard-pressure pneumoperitoneum, prolonged pneumoperitoneum, myocardial injuries, troponin T(TnT), Trendelenburg position, chest CT scan, low-pressure pneumoperitoneum, robot-assisted surgery
Eligibility Criteria
Inclusion Criteria:
- Patients who are scheduled to undergo Robot-assisted radical prostatectomy or other robot-assisted urological surgeries last longer than 3 hours
- Patients who are classified as American Society of Anesthesiologists(ASA)I and II
- Patient's preoperative troponin T(TnT) level is normal
Exclusion Criteria:
- Patients with preoperative cardiopulmonary dysfunction who can not understand prolonged surgeries in the Trendelenburg position:severe pulmonary dysfunction or New York Heart Association(NYHA) classification is Ⅲ-Ⅳ.
- Body Mass Index>30.
- Any intraoperative situation as follows:1. Any cause to cancel operation or change robot-assisted surgery to open surgery 2. Intraoperative cardiovascular accidents.
Sites / Locations
- Ruijin Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
low-pressure pneumoperitoneum group
standard-pressure pneumoperitoneum group
Subjects assigned to the low-pressure pneumoperitoneum group will receive 7-10 mm Hg carbon dioxide pneumoperitoneum, and the expected duration is longer than 3 hours to complete robot-assisted surgeries in the Trendelenburg position;
Subjects assigned to the standard-pressure pneumoperitoneum group will receive 12-16 mm Hg carbon dioxide pneumoperitoneum, which is expected lasted longer than 3 hours to complete robot-assisted surgeries in the Trendelenburg position;